Wells Fargo & Company Moderna, Inc. Call Options Transaction History

Wells Fargo & Company

6 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q3 2024 Nov 13, 2024	BUY	$63.64 - $125.14 $534,576 - $1.05 Million	8,400 Added 204.88%	12,500 $835,000
Q2 2024 Aug 13, 2024	SELL	$101.21 - $166.61 $1.61 Million - $2.65 Million	-15,900 Reduced 79.5%	4,100 $486,000
Q1 2024 May 10, 2024	SELL	$85.37 - $115.44 $5.98 Million - $8.08 Million	-70,000 Reduced 77.78%	20,000 $2.13 Million
Q4 2023 Feb 09, 2024	BUY	$69.51 - $104.43 $6.26 Million - $9.4 Million	90,000 New	90,000 $8.95 Million
Q2 2023 Aug 15, 2023	BUY	$118.5 - $160.53 $402,900 - $545,802	3,400 Added 566.67%	4,000 $486,000
Q4 2022 Feb 13, 2023	BUY	$118.38 - $210.04 $71,028 - $126,024	600 New	600 $107,000

953

240M

10.6M

18.7M

Ticker MRNA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 391,200,000
Market Cap $15.4B
Description
Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...

Get notified when there are updates to the investment portfolio of Wells Fargo & Company, based on Form 13F filings with the SEC.

Stay updated on Wells Fargo & Company with notifications on news.